Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.
Rosanne SpruteJan-Hendrik GrotheSarah HeringerOliver Andreas CornelyPublished in: The Journal of antimicrobial chemotherapy (2022)
This study identified barriers to enrolment in clinical trials assessing novel antifungal agents in invasive candidiasis. Identification of eligibility criteria associated with non-enrolment allows modification of future trial designs and may ultimately result in higher recruitment rates.